Mesothelioma: No Cure Yet, But Much Promise in New TherapiesMary Hesdorffer
The most typical cell types for mesothelioma cancer are sarcomatoid and epithelioid. What Is Malignant Pleural Mesothelioma Pleural mesothelioma is the most common type of asbestos-related cancer. Though itâs an aggressive illness, ongoing advancements in chemotherapy, surgery and clinical trials are ex...
November 11, 2020 Novocure Receives CE Mark for NovoTTF-100L™ System The application of CE mark enables Novocure to commercialize the NovoTTF-100L System as a treatment for Malignant Pleural Mesothelioma in the European Union and Switzerland ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (...
adult patients with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic ...
And we're continuing on this path forward. The benefit we have right now, in essence, is we can use the GBM franchise and expand beyond where we are today in other European geographies. And as you heard from Asaf's opening remarks with the pending CE Mark for mesothelioma, that offers ...
products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung ...
Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division of solid tumor cancer cells. The company markets TTF-based delivery systems: Optune Lua for the treatment of malignant pleural mesothelioma; and Optune for the...
The modulation of autophagy represents a potential therapeutic strategy for cancer. More than one hundred clinical trials have been conducted or are ongoing to explore the efficacy of autophagy modulators to reduce the tumor growth and potentiate the anti-cancer effects of conventional therapy. Despite...
Making Cents of Mesothelioma Katie Kosko December 14th 2020 A new grant program offers financial assistance for patients with mesothelioma who must travel for cancer care. Read MoreCancerCare Celebrates 75 Years of Serving the Cancer Community February 5th 2019 Read More...
Sure. Thank you for the question. What I would comment on is how we built our business in GBM and mesothelioma. What we realize is that both of those diseases and some of the other diseases that we are investigating in our multidisciplinary diseases, where many specialties play a key role...